TOKYO, Apr 08 (Pulse News Wire) – Accrete Inc. (4395.T) announced today that its board of directors has approved a joint venture agreement with CustIntCo Pte Ltd, based in Singapore.
The joint venture, named CustIntCo Japan Co., Ltd., aims to develop high-value solutions using advanced AI technologies for mental health care in various industries. The joint venture will focus on providing Genie AI Engine services, which analyze mental health states from voice data within approximately one minute and measure vital signs non-invasively from facial images. These services will be integrated into Accrete's existing product ANOTHER AI through API connections, enabling broader application across sectors such as logistics, healthcare, retail, and call centers.
Key details of the joint venture include: - Capital: ¥10 million - Establishment Date: April 2026 (planned) - Initial Shareholding Ratio: Accrete Inc. 51%, CustIntCo Pte Ltd 49%; post foreign exchange law approval, shares will adjust to Accrete Inc. 51% and CustIntCo Pte Ltd 49% Operations are set to commence in mid-May 2026, with the joint venture becoming part of Accrete’s consolidated financial statements thereafter.
The impact on Accrete's fiscal year ending December 2026 will be assessed further and disclosed promptly if significant changes arise.
🟢 Confidence: High AI-translated content.